MedTrace Logo

Prevention of Perioperative Hypothermia in Patients Submitted to Transurethral Resection

NCT03630887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2020-06-11

No results posted yet for this study

Summary

Hypothermia is a frequent perioperative complication. When the negative effects of anesthesia on temperature are aggravated by other factors, such as glycine infusion in transurethral resection, temperature can decrease even more. Preoperative warming prevents hypothermia, lowering the temperature gradient between core and peripheral compartments and reducing thermal redistribution. The most recent clinical practice guidelines advocate for active prewarming before induction of general anaesthesia since it is very effective in preventing perioperative hypothermia. However, the ideal warming time prior to the induction of anesthesia has long been investigated. This study aims to evaluate the optimal time period of preoperative forced-air warming to reduce the incidence of hypothermia at the end of surgery in patients submitted to transurethral resection. This is a clinical trial comparing different time periods of prewarming in patients submitted to undergo elective transurethral resection. We will compare different time periods: 0 minutes (control group), 15 minutes, 30 minutes and 45 minutes. 144 patients are going to be included in this study (36 patients in each group). Measurement of temperature will be performed using a tympanic thermometer. Patients will be followed throughout their hospital admission. Data will be recorded using a validated instrument and will be analysed using the statistics program R Core Team.

Conditions

  • Hypothermia; Anesthesia
  • Perioperative/Postoperative Complications
  • Complication of Anesthesia
  • Temperature Change, Body
  • Anaesthesia Complication
  • Transurethral Resection Syndrome

Interventions

DEVICE

WarmTouch Model 5900, Covidien Ltd, Mansfield, USA

Forced-air warming will be applied in the preanesthetic room during different time periods.

Sponsors & Collaborators

  • University of Las Palmas de Gran Canaria

    collaborator OTHER

  • Dr. Negrin University Hospital

    lead OTHER

Principal Investigators

  • Ángel Becerra, MD · Dr. Negrin University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-14
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630887 on ClinicalTrials.gov